129 related articles for article (PubMed ID: 29783307)
1. Will personalized medicine help in 'transforming' the business of healthcare?
Lester DS
Per Med; 2009 Sep; 6(5):555-565. PubMed ID: 29783307
[TBL] [Abstract][Full Text] [Related]
2. Biopharmaceutical industry perspectives on the business prospects for personalized medicine.
Milne CP; Zuckerman R
Per Med; 2011 Sep; 8(5):541-550. PubMed ID: 29793252
[TBL] [Abstract][Full Text] [Related]
3. Molecular diagnostics and personalized medicine: value-assessed opportunities for multiple stakeholders.
Blair ED
Per Med; 2010 Mar; 7(2):143-161. PubMed ID: 29783325
[TBL] [Abstract][Full Text] [Related]
4. Innovative tests for patient-tailored treatments: demonstrating value in the age of personalized medicine.
Housman L
Per Med; 2011 Mar; 8(2):183-189. PubMed ID: 29783409
[TBL] [Abstract][Full Text] [Related]
5. Personalized medicine: the absence of 'model-changing' financial incentives.
Keeling P
Per Med; 2007 Feb; 4(1):73-81. PubMed ID: 29793300
[TBL] [Abstract][Full Text] [Related]
6. Impact of molecular medicine on healthcare markets and strategies for success.
Miller PS; Batchelder KF
Per Med; 2009 Sep; 6(5):529-542. PubMed ID: 29783311
[TBL] [Abstract][Full Text] [Related]
7. A coalition to drive personalized medicine forward.
Munroe JB
Per Med; 2004 Dec; 1(1):9-13. PubMed ID: 29793218
[TBL] [Abstract][Full Text] [Related]
8. Company Profile: Center for Business Models in Healthcare.
Trosman JR; Weldon CB
Per Med; 2013 Jun; 10(4):333-337. PubMed ID: 29783420
[TBL] [Abstract][Full Text] [Related]
9. Economic viability of Stratified Medicine concepts: An investor perspective on drivers and conditions that favour using Stratified Medicine approaches in a cost-contained healthcare environment.
Fugel HJ; Nuijten M; Postma M
N Biotechnol; 2016 Dec; 33(6):860-867. PubMed ID: 27664792
[TBL] [Abstract][Full Text] [Related]
10. Driving forces behind the past and future emergence of personalized medicine.
Steffen JA; Steffen JS
J Pers Med; 2013 Jan; 3(1):14-22. PubMed ID: 25562408
[TBL] [Abstract][Full Text] [Related]
11. Challenges of implementing personalized (precision) medicine: a focus on diabetes.
Fodor A; Karnieli E
Per Med; 2016 Sep; 13(5):485-497. PubMed ID: 29767596
[TBL] [Abstract][Full Text] [Related]
12. Assessing value of innovative molecular diagnostic tests in the concept of predictive, preventive, and personalized medicine.
Akhmetov I; Bubnov RV
EPMA J; 2015; 6():19. PubMed ID: 26425215
[TBL] [Abstract][Full Text] [Related]
13. Towards a framework for personalized healthcare: lessons learned from the field of rare diseases.
Tambuyzer E
Per Med; 2010 Sep; 7(5):569-586. PubMed ID: 29776250
[TBL] [Abstract][Full Text] [Related]
14. Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcare.
Simmons LA; Dinan MA; Robinson TJ; Snyderman R
Per Med; 2012 Jan; 9(1):85-91. PubMed ID: 29783292
[TBL] [Abstract][Full Text] [Related]
15. Challenges in the codevelopment of companion diagnostics.
Moore MW; Babu D; Cotter PD
Per Med; 2012 Jul; 9(5):485-496. PubMed ID: 29768776
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and health economic challenges of personalized medicine].
Brüggenjürgen B; Kornbluth L; Ferrara JV; Willich SN
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):710-4. PubMed ID: 22526860
[TBL] [Abstract][Full Text] [Related]
17. State of the industry for drug-diagnostic development: challenge and change on the path to precision medicine.
Milne CP; Cohen J; Chakravarthy R; Awatin J
Per Med; 2016 Jul; 13(4):337-345. PubMed ID: 29749814
[TBL] [Abstract][Full Text] [Related]
18. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
19. Benefit-risk management in the age of personalized healthcare.
Forstner M
Per Med; 2012 Jul; 9(5):507-514. PubMed ID: 29768767
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
